Chronic alcoholism causes deleterious conditioning of innate immunity

Alcohol and Alcoholism

Volumn 39, Issue 5, 2004, Pages 386-392

  Frank, Johannes ^a   Witte, Karin ^b   Schrödl, Wieland ^c   Schütt, Christine ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Johanna Odebrecht Foundation   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTIBODY; CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PHORBOL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL WITHDRAWAL; ALCOHOLISM; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EX VIVO STUDY; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; INCIDENCE; INFECTION; LIVER DISEASE; MALE; MONOCYTE; PRIORITY JOURNAL; SEPSIS; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ALCOHOLISM; ANTIGENS, CD14; CARRIER PROTEINS; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOL; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; INTERLEUKINS; INVERTEBRATE HORMONES; MALE; PHYSICAL EXAMINATION; QUESTIONNAIRES; SUBSTANCE WITHDRAWAL SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4544259391     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/agh083     Document Type: Article

References (60)

1. Abraham, E., Wunderink, R., Silverman, H., Perl, T. M., Nasraway, S., Levy, H., Bone, R., Wenzel, R. P., Balk, R. and Allred, A. (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial. JAMA 273, 934-941.
2. Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W. and Thurman, R.G. (1995) Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108, 218-224.
3. Astiz, M. E., Rackow, E. C., Still, J. G., Howell, S. T., Cato, A., Von Eschen, K. B., Ulrich, J. T., Rudbach, J. A., McMahon, G. and Vargas, R. (1995) Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Critical Care Medicine 23, 9-17.
4. Aube, H., Milan, C. and Blettery, B. (1992) Risk factors for septic shock in the early management of bacteremia. American Journal of Medicine 93, 283-288.
5. Beeson, P. B. (1947) Tolerance to bacterial pyrogens. I. Factors influencing its development. Journal of Experimental Medicine 86, 29-38.
6. Bode, C., Kugler, V. and Bode, J. C. (1987) Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. Journal of Hepatology 4, 8-14.
7. Bone, R. C., Fisher, C. J. Jr, Clemmer, T. P., Slotman, G. J., Metz, C. A. and Balk R. A. (1989) Sepsis syndrom: A valid clinical entity. Critical Care Medicine 17, 389-393.
8. Brock-Utne, J. G., Gaffin, S. L., Wells, M. T., Gathiram, P., Sohar, E., James, M. F., Morrell, D. F. and Norman, R. J. (1988) Endotoxaemia in exhausted runners after a long-distance race. South African Medical Journal 73, 533-536.
9. Cohen, J. (2000) The detection and interpretation of endotoxaemia. Intensive Care Medicine 26, 51-56.
10. Cross, A. S. (2002) Endotoxin tolerance - current concepts in historical perspective. Journal of Endotoxin Research 8, 83-98.
11. Döcke, W. D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H. D. and Kox, W. (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nature Medicine 3, 678-681.
12. Echternacher, B., Weigl, K., Lehn, N. and Männel, D. N. (2001) tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infection and Immunology 69, 3550-3555.
13. Enomoto, N., Ikejima, K., Bradford, B., Rivera, C., Kono, H., Brenner, D. A. and Thurman, R. G. (1998) Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 115, 443-451.
14. Erroi, A., Fantuzzi, G., Mengozzi, M., Sironi, M., Orencole, S. F., Clark, B. D., Dinarello, C. A., Isetta, A., Gnocchi, P. and Giovarelli, M. (1993) Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infection and Immunology 61, 4356-4359.
15. Ertel, W., Keel, M., Neidhadt, R., Steckholzer, U., Kremer, J. P., Ungethuem, U. and Trentz, O. (1997) Inhibition of the defense system stimulating interleukin 12 interferon-γ pathway during critical illness. Blood 89, 1612-1620.
16. Ertel, W., Kremer, J. P., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O. and Schildberg, F. W. (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85, 1341-1347.
17. Fisher, C. J. Jr, Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C. and Catalano, M. A. (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Critical Care Medicine 22, 12-21.
18. Fisher, C. J. Jr, Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H. and Benjamin, E. (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. New England Journal of Medicine 334, 1697-1702.
19. Gogos, C. A., Drosou, E., Bassaris, H. P. and Skoutelis, A. (2000) Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. Journal of Infectious Diseases 181, 176-180.
20. Gransden, W. R., Eykyn, S. J., Phillips, I. and Rowe, B. (1990) Bacteremia due to Escherichia coli: A study of 861 episodes. Review of Infectious Diseases 12, 1008-1018.
21. Grunwald, U., Krüger, C., Westermann, J., Lukowsky, A., Ehlers, M. and Schütt, C. (1992) An enzymelinked immunosorbent assay for the quantification of solubilized CD14 in biological fluids. Journal of Immunological Methods 155, 225-232.
22. Heinrich, J. M., Bernheiden, M., Minigo, G., Yang, K. K., Schütt, C., Männel, D. N. and Jack, J. S. (2001) The essential role of lipopolysaccharide-binding protein in protection of mice against a peritoneal salmonella infection involves the rapid induction of inflammatory response. Journal of Immunology 167, 1624-1628.
23. Hensler, T., Heidecke, C. D., Hecker, H., Heeg, K., Bartels, H., Zanzl, N., Wagner, H., Siewert, J. R. and Holzmann, B. (1998) Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. Journal of Immunology 161, 2655-2659.
24. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G. and Karl, I. E. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. Journal of Immunology 166, 6952-6963.
25. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Grayson, M. H., Osborne, D. F., Wagner, T. H., Cobb, J. P., Coopersmith, C. and Karl, I. E. (2002) Depletion of dendritic cells, but not macrophages, in patients with sepsis. Journal of Immunology 168, 2493-2500.
26. Hotchkiss, R. S. and Karl, I. E. (2003) The pathophysiology and treatment of sepsis. New England Journal of Medicine 348, 138-150.
27. Jack, R. S., Fan, X., Bernheiden, M., Rune, G., Ehlers, M., Weber, A., Kirsch, G., Mentel, R., Fürll, B., Freudenberg, M., Schmitz, G., Stelter, F. and Schütt, C. (1997) Lipopolysaccharide binding protein is required to combat a murine Gram-negative bacterial infection. Nature 389, 742-745.
28. Karp, C. L., Wysocka, M., Ma, X., Marovich, M., Factor, R. E., Nutman, T., Armant, M., Wahl, L., Cuomo, P. and Trinchieri, G. (1998) Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. European Journal of Immunology 28, 3128-3136.
29. Kitchens, R. L., Thompson, P. A., Viriyakosol, S., O'Keefe, G. E. and Munford, R. S. (2001) Plasma CD14 decrases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoprotein. Journal of Clinical Investigation 108, 484-493.
30. Lederer, J. A., Rodrick, M. L. and Mannick, J. A. (1999) The effects of injury on the adaptive immune response. Shock 11, 153-159.
31. Leibovici, L., Drucker, M., Konigsberger, H., Samra, Z., Harrari, S., Ashkenazi, S. and Pitlik, S. D. (1997) Septic shock in bacteremic patients: Risk factors, features and prognosis. Scandinavian Journal of Infectious Disease 29, 71-75.
32. Ling, P., Gately, M. K., Gubler, U., Stern, A. S., Lin, P., Hollfelder, K., Su, C., Pan, Y. C. and Hakimi, J. (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. Journal of Immunology 154, 116-127.
33. Morgan, H. R. (1948) Resistance to the action of enteric bacilli in man. Journal of Clinical Investigation 27, 706-709.
34. Munoz, C., Carlet, J., Fitting, C., Misset, B., Bleriot, J. P. and Cavaillon, J. M. (1991) Dysregulation of the in vitro cytokine production by monocytes during sepsis. Journal of Clinical Investigation 88, 1747-1754.
35. National Institute of Health (2000) Alcohol and the immune system. In 10th Special Report to the U.S. Congress on Alcohol and Health, pp. 214-235. NIH Bethesda, ML.
36. O'Suilleabhain, C., O'Sullivan, S. T., Kelly, J. L., Lederer, J., Mannick, J. A. and Rodrick, M. L. (1996) Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 120, 290-296.
37. O'Sullivan, S. T., Lederer, J. A., Horgan, A. F., Chin, D. H., Mannick, J. A. and Rodrick, M. L. (1995) Major injury leads to predominance of the Thelper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Annals of Surgery 222, 482-492.
38. Oberholzer, A., Oberholzer, C. and Moldawer, L. L. (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16, 83-96.
39. Opal, S. M. and DePalo, V. A. (2000) Anti-inflammatory cytokines. Chest 177, 1162-1172.
40. Parlesak., A., Schäfer, C., Schutz, T., Bode, J. C. and Bode, C. (2000) Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. Journal of Hepatology 32, 742-747.
41. Peterson, J. D., Vasquez, K. and Walthenbaugh, C. (1998) Interleukin-12 therapy restores cell mediated immunity in ethanol-consuming mice. Alcohol: Clinical and Experimental Research 22, 245-251.
42. Pittet, D., Rangel-Frausto, S., Li, N., Tarara, D., Costigan, M., Rempe, L., Jebson, P. and Wenzel, R. P. (1995) Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcome in surgical ICU patients. Intensive Care Medicine 21, 302-309.
43. Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckermann, H., Platzer, C. and Volk, H. D. (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. Journal of Experimental Medicine 181, 1887-1892.
44. Randow, F., Döcke, W. D., Bundschuh, D. S., Hartung, T., Wendel, A. and Volk, H. D. (1997) In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma IL-12 and granulocyte-macrophage colony-stimulating factor. Journal of Immunology 158, 2911-2918.
45. Reid, R. R., Prodeus, A. P., Khan, W., Hsu, T., Rosen, F. S. and Carroll, M. C. (1997) Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. Journal of Immunology 159, 970-975.
46. Reinhart, K. and Karzai, W. (2001) Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Critical Care Medicine 29 (Suppl.), S121-S125.
47. Schilling, T., Wiersbitzky, M., Urbaschek, R., Schilling, S., Jahn, A., Grunwald, U. and Schütt, C. (1995) Immunological parameters of alcoholics suffering from infection or sepsis in the ICU. Alcohol and Alcoholism 30, 518.
48. Schroedl, W., Fuerll, B., Reinhold, P., Krueger, M. and Schuett, C. (2001) A novel acute phase marker in cattle: lipopolysaccharide binding protein (LBP). Journal of Endotoxin Research 7, 49-52.
49. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S. and Ulevitch, R. J. (1990) Structure and function of lipopolysaccharide binding protein. Science 249, 1429-1431.
50. Singhal, P. C., Reddy, K., Ding, G., Kapasi, A., Franki, N., Ranjan, R., Nwakoby, I. E. and Gibbons, N. (1999) Ethanol-induced macrophage apoptosis: the role of TGF-β. Journal of Immunology 162, 3031-3036.
51. Slotman, G. J. and Quinn, J. V. (1997) Multivariate regression modeling for the prediction of inflammation, systemic pressure, and end-organ function in severe sepsis. Shock 8, 225-231.
52. Trinchieri, G. (2003) IL12 and the regulation of innate resistance and adaptive immunity. Nature Reviews Immunology 3, 133-145.
53. Urbaschek, R., McCuskey, R. S., Rudi, V., Becker, K. P., Stickel, F., Urbaschek, B. and Seitz, H. K. (2001) Endotoxin endotoxin-neutralizing-capacity sCD14 sICAM-1 and cytokines in patients with various degrees of alcoholic liver disease. Alcohol: Clinical and Experimental Research 25, 261-268.
54. Volk, H. D., Thieme, M., Ruppe, U., Heym, S., Döcke, W. D., Manger, D., Zuckermann, S., Golosubow, A., Nieter, B., Klug, H. et al. (1993) Alterations in fuction and phenotype of monocytes from patients with septic disease: predictive value and new therapeutic strategies. In Host Defense Dysfunction in Trauma Shock and Sepsis, Faist, E. and Meakins, J. L. eds, pp. 246-252. Springer, Berlin.
55. Vreugdenhil, A. C., Snoek, A. M., van 't Veer, C., Greve, J. W. and Buurman, W. A. (2001) LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. Journal of Clinical Investigation 107, 225-234.
56. West, M. A., LeMieur, T., Clair, L., Bellingham, J. and Rodriguez, J. L. (1997) Protein kinase C regulates macrophages tumor necrosis factor secretion: direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery 122, 204-211.
57. Wysocka, M., Robertson, S., Riemann, H., Caamano, J., Hunter, C., Mackiewicz, A., Montaner, L. J., Trinchieri, G. and Karp, C. L. (2001) IL-12 suppression during experimental endotoxin tolerance: dendritic cells loss and macrophage hyporesponsiveness. Journal of Immunology 166, 7504-7513.
58. Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I. and Thurman, R. G. (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver-injury. Gastroenterology 117, 942-952.
59. Yin, M., Bradford, B. U., Wheeler, M. D., Uesugi, T., Froh, M., Goyert, S. M. and Thurman, R. G. (2001) Reduced early alcohol-induced liver injury in CD14-deficient mice. Journal of Immunology 166, 4737-4742.
60. Ziegler-Heitbrock, H. W., Blumenstein, M., Kafferlein, E., Kieper, D., Petersmann, I., Endres, S., Flegel, W. A., Northoff, H., Riethmuller, G. and Haas, J. G. (1992) In vitro desensitization to lipopolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 75, 264-268.